IRVINE, Calif., Oct. 2, 2007 (PRIME NEWSWIRE) -- "Revenue projections and forecasts are most often welcomed by investors seeking guidance on companies of interest. And sometimes the stuff of optimism is a short deductive leap from a pretty bold press release that reports that a company has ordered 50,000 cases of its top-seller from its co-packer with a retail value exceeding $1.5 million that would result in approximately $1.2 million in revenues to the company," stated SmallCap Sentinel analyst D.R. Clark. "But that's what appears to be happening with Sweet Success (OTCBB:SWTS), which just announced after-market Monday that they are ramping production to accommodate the recently expanded GlucaSafe(tm) health-beverage customer base."
A comprehensive report focusing on beverage maker Sweet Success Enterprises, and of interest to investors in Hansen Natural Corporation (Nasdaq:HANS), The Coca Cola Company (NYSE:KO), and Pepsico. (NYSE:PEP) has been published by financial courier StockUpTicks.com and is available free of charge to the general public at the link below:
To view the report in its entirety, please visit: http://stockupticks.com/profiles/5-2-07.html
"It's clear that Sweet Success is confident in their progress, and a simple review of recent headlines and some dot-connecting might serve to increase interest in the intriguing beverage company," Clark added.
San Antonio-based Sweet Success Enterprises, Inc. acquired Nestle's original Sweet Success(tm) brand in 2002 and has re-launched a product line to tap into the rapidly growing demand for convenient and nutritious functional beverages. GlucaSafe is enhanced with the popular diabetic health maintenance tool Cinnulin. This multifunctional health beverage is packed with the healthy antioxidant powers of green and white tea and delicious pomegranate extract.
To have your company featured on StockUpTicks.com or SmallCap Sentinel please use the contact info below.
The SmallCap Sentinel logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3664
These statements have not been evaluated by the FDA. Sweet Success products are not intended to diagnose, treat, cure or prevent disease.
Statements herein contain forward-looking statements and are subject to significant risks and uncertainties affecting results. SmallCap Sentinel/StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to accuracy or completeness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP isn't an investment advisor and this report isn't investment advice. MP has been paid 325,000 restricted shares by Sweet Success for preparation/distribution of this report and other advertising services over a six-month period. This constitutes a conflict of interest as to MP's ability to remain objective in communication regarding the subject company.